Clonality Analysis of Hematopoiesis and Thrombopoietin Levels in Patients with Essential Thrombocythemia

References

• Murphy S., Hand H., Rosenthal D., Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Blood 1986; 23: 177–182
   Google Scholar
• Pearson T. C. Primary thrombocythemia: diagnosis and management. British Journal of Haematology 1991; 78: 145–148
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Faguet G. B., Jacobson R. J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• Gaetani G. F., Ferraris A. M., Galiano S., Giuntini P., Canepa L., Urso M. Primary thrombocythemia: clonal origin of platelets, erythrocytes and granulocytes in A GdB/GdMediterranean subjects. Blood 1982; 59: 76–79
   PubMed Web of Science ®Google Scholar
• Anger B., Janssen J. W. G., Schrezenmeier H., Hehlmann R., Heimpel H., Bartram C. R. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 1990; 4: 258–261
   PubMed Web of Science ®Google Scholar
• Janssen J. W., Anger B. R., Drexler H. G., Bartram C. R., Heimpel H. Essential thrombocythemia in two sisters originating from different stem cell levels. Blood 1990; 75: 1633–1636
   PubMed Web of Science ®Google Scholar
• Turhan A. G., Cashman J. D., Eaves C. J., Humphries R. K., Eaves A. C. Variable expression of features of normal and neoplastic stem cells in patients with thrombocytosis. British Journal of Haematology 1992; 82: 50–57
   PubMed Web of Science ®Google Scholar
• Tsukamoto N., Morita K., Maehara T., Okamoto K., Sakai H. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. British Journal of Haematology 1994; 86: 253–258
   PubMed Web of Science ®Google Scholar
• Lyon M. F. Gene action in the X-chromosome of the mouse. Nature 1961; 190: 372
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Feinberg A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985; 227: 642–645
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Boulos P., Linch D. C. Tissue specificity of X-chromosome inactivation pattens. Blood 1994; 83: 2899–2905
   PubMed Web of Science ®Google Scholar
• Prchal J. T., Guan Y. L. A novel clonality assay based on transcriptional analysis of the active X-chromosome. Stem Cells 1993; 11: 62–65
   PubMed Web of Science ®Google Scholar
• Busque L., Mio R., Mattioli J., Brais E., Blais N., Lalonde Y., et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996; 88: 59–65
   PubMed Web of Science ®Google Scholar
• Tan S. S., Williams E. A., Tarn P. P. L. X-chromosome inactivation occurs at different times in different tissues of the post-implantation mouse embryon. Nature Genetics 1993; 3: 170–174
   PubMed Web of Science ®Google Scholar
• Fialkow P. J. Primordial cell pool size and lineage relationships of five humen cell types. Annals of Human Genetics 1973; 37: 39–48
   PubMed Web of Science ®Google Scholar
• Fey M. F., Peter H. J., Hinds H. L., Zimmermann A., Liechti-Gallati S., Gerber H., Suder H., Tobler A. Clonal analysis of human tumors with M27β, a highly informative polymorphic X chromosomal probe. Journal of Clinical Investigation 1992; 89: 1438–1444
   PubMed Web of Science ®Google Scholar
• De Sauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wong S. C., Kuang W. J., Wong S. C., Kuang W. J., Oles K. J., Hultgren B., Solberg L. A., Jr, Goeddel D. V., Eaton D. L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533–538
   PubMed Web of Science ®Google Scholar
• Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Heipel M. D., Burkhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F. T., Mathewes S. L., Bailey M. C., Forstrom J. W., Buddie M. M., Osborn S. G., Evans S. J., Sheppard P. O., Presnell S. R., O'Hara P. J., Hagen F. S., Roth G. J., Foster D. C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565–568
   PubMed Web of Science ®Google Scholar
• Wendling F., Maraskovsky E., Debili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369: 571–574
   PubMed Web of Science ®Google Scholar
• Bartley T. D., Bogenberger J., Hunt P., Li Y. S., Lu H. S., Martin F., Chang M. S., Samal B., Nichol J. L., Swift S., Johnson M., Hsu R. Y., Parker V. P., Suggs S., Skrine J. D., Merewether L. A., Clogston C., Hsu E., Hokom M. M., Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sieu L., Padilla D., Trail G., Elliott G., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Del Castillo J., Biron J., Cole S., Hu M., Pacifici R., Ponting I., Saris C., Wen D., Yung Y. P., Lin H., Bosselman R. A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117–1124
   PubMed Web of Science ®Google Scholar
• Sohma Y., Akahori H., Seki N., Hori T., Ogami K., Kato T., Shimada Y., Kawamura K., Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Letters 1994; 353: 57–61
   PubMed Web of Science ®Google Scholar
• Kuter D. J., Beeler D. L., Rosenberg R. D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 11104–11108
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddie M. M., Oort P. J., Hagen F. S., Roth G. J., Papayannopoulou T., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin [see comments]. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• Banu N., Wang J. F., Deng B., Groopman J. E., Avraham H. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood 1995; 86: 1331–1338
   PubMed Web of Science ®Google Scholar
• El Kassar N., Hetet G., Li Y., Briere J., Grandchamp B. Clonal analysis of haematopoietic cells in essential thrombocythaemia. British Journal of Haematology 1995; 90: 131–137
   PubMed Web of Science ®Google Scholar
• El Kassar N., Hetet G., Briere J., Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T-lymphocytes and platelets. Blood 1997; 89: 128–134
   PubMed Web of Science ®Google Scholar
• Raskind W. H., Jacobson R., Murphy S., Adamson J. W., Fialkow P. J. Evidence for the involvement of B-lymphoid cells in polycythemia vera and essential thrombocythemia. Journal of Clinical Investigation 1985; 75: 1388–1390
   PubMed Web of Science ®Google Scholar
• Gilliland D. G., Blanchard K. L., Levy J., Perrin S., Bunn H. F. Clonality in myeloproliferative disorders. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 6848–6852
   PubMed Web of Science ®Google Scholar
• Allen R. C., Zoghbi H. Y., Moseley A. B., Rosenblatt H. M., Belmont J. W. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics 1992; 51: 1229–1239
   PubMed Web of Science ®Google Scholar
• Prchal J. T., Liu Y., Prchal J. F., Hoffman R., Tushinski R. Are normal stem cells present in myeloproliferative syndrome?. Blood 1994; 84, abstract 207.
   Web of Science ®Google Scholar
• El-Kassar N., Hetet G., Briere J., Grandchamp B. X-chromosome inactivation in normal females: incidence of excessive lyonizationwith age and comparison of assays using DNA methylation and transcript polymorphisms. Clinical Chemistry, Submitted.
   PubMed Web of Science ®Google Scholar
• Versteeg R. Aberrant methylation in cancer. American Journal of Human Genetics 1997; 60: 751–754
   PubMed Web of Science ®Google Scholar
• Taylor K., Pitcher L., Nichol J., Selesi D., Rodwell R., Marty J., Taylor D., Wright S., Moore D., Kelly C., Rentoul A. Inappropriate elevation and loss of feedback regulation of thrombopoietin in essential thrombocythaemia (ET). Blood 1995; 86, suppll, 183a.
   Web of Science ®Google Scholar
• Wang J. C., Chen C., Nicol J. Serum thrombopoietin (TPO) levels in patients with Essential thrombocytosis (ET) & reactive thrombocytosis (RT). Blood 1996; 88, suppl, 3576a.
   Web of Science ®Google Scholar
• Ulich T. R., Del Castillo J., Yin S., Swift S., Padilla D., Senaldi G., Bennett L., Shutter J., Bogenberger J., Sun D., Samal B., Shimamoto G., Lee R., Steinbrink R., Boone T., Sheridan W. T., Hunt P. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971–976
   PubMed Web of Science ®Google Scholar
• Kuter D. J., Rosenberg R. D. Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood 1994; 84: 1464–1472
   PubMed Web of Science ®Google Scholar
• Fielder P. J., Gurney A. L., Stefanich E., Marian M., Moore M. W., Carver-Moore K., De Sauvage F. J. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996; 87: 2154–2161
   PubMed Web of Science ®Google Scholar
• Emmons R. V., Reid D. M., Cohen R. L., Meng G., Young N. S., Dunbar C. E., Shulman N. R. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068–4071
   PubMed Web of Science ®Google Scholar
• Shivdasani R. A., Rosenblatt M. F., Zucker-Franklin D., Jackson C. W., Hunt P., Saris C. J., Orkin S. H. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995; 81: 695–704
   PubMed Web of Science ®Google Scholar
• Stoffel R., Wiestner A., Skoda R. C. Thrombopietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567–573
   PubMed Web of Science ®Google Scholar
• Cohen-Solal K., Villeval J. L., Titeux M., Lok S., Vainchenker W., Wendling F. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 1996; 88: 2578–2584
   PubMed Web of Science ®Google Scholar
• McCarty J. M., Sprugel K. H., Fox N. E., Sabath D. E., Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668–3675
   PubMed Web of Science ®Google Scholar
• Sungaran R., Markovic B., Chong B. H. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridation. Blood 1997; 89: 101–107
   PubMed Web of Science ®Google Scholar